Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients with Diffuse Large B-cell Lymphoma Treated with Rituximab and CHOP

By Mitrović Zdravko  

Pathology & Oncology Research, Vol. 17, Iss. 2, 2011-06 ,pp. : 243-247

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic Significance of Ki-67 Nuclear Proliferative Antigen, bcl-2 Protein, and p53 Expression in Follicular and Diffuse Large B-Cell Lymphoma

By Llanos M.   Alvarez-Argüelles H.   Alemán R.   Oramas J.   Díaz-Flores L.   Batista N.  

Medical Oncology, Vol. 18, Iss. 1, 2001-03 ,pp. : 15-22

Humana Press, Inc

Access to resources Recommend Favorite

Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy

By                          

Experimental and Therapeutic Medicine, Vol. 6, Iss. 1, 2013-01 ,pp. : 109-114

Spandidos Publications

Access to resources Recommend Favorite

Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study

By                  

Experimental and Therapeutic Medicine, Vol. 4, Iss. 3, 2012-01 ,pp. : 475-480

Spandidos Publications

Access to resources Recommend Favorite

Prognostic evaluation of immunohistochemical profiles in diffuse large B-cell lymphoma: a Chinese study

By Chen Zi  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 241-248

Humana Press, Inc

Access to resources Recommend Favorite